Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux
Open Access
- 26 January 2014
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 20 (2) , 152-158
Abstract
Although the classical antibiotic spectinomycin is a potent bacterial protein synthesis inhibitor, poor antimycobacterial activity limits its clinical application for treating tuberculosis. Using structure-based design, we generated a new semisynthetic series of spectinomycin analogs with selective ribosomal inhibition and excellent narrow-spectrum antitubercular activity. In multiple murine infection models, these spectinamides were well tolerated, significantly reduced lung mycobacterial burden and increased survival. In vitro studies demonstrated a lack of cross resistance with existing tuberculosis therapeutics, activity against multidrug-resistant (MDR) and extensively drug-resistant tuberculosis and an excellent pharmacological profile. Key to their potent antitubercular properties was their structural modification to evade the Rv1258c efflux pump, which is upregulated in MDR strains and is implicated in macrophage-induced drug tolerance. The antitubercular efficacy of spectinamides demonstrates that synthetic modifications to classical antibiotics can overcome the challenge of intrinsic efflux pump-mediated resistance and expands opportunities for target-based tuberculosis drug discovery.Keywords
This publication has 61 references indexed in Scilit:
- Mouse Model for Efficacy Testing of Antituberculosis Agents via Intrapulmonary DeliveryAntimicrobial Agents and Chemotherapy, 2012
- Nonsense mutations in the COX1 subunit impair the stability of respiratory chain complexes rather than their assemblyThe EMBO Journal, 2012
- Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux MechanismCell, 2011
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2009
- A simple in vitro PK/PD model system to determine time–kill curves of drugs against MycobacteriaTuberculosis, 2009
- Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicityProceedings of the National Academy of Sciences, 2008
- A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agentsJournal of Antimicrobial Chemotherapy, 2008
- Mitochondrial deafness alleles confer misreading of the genetic codeProceedings of the National Academy of Sciences, 2008
- Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteriaNucleic Acids Research, 2007